Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

被引:12
作者
Tosh, Dilip K. [1 ]
Ciancetta, Antonella [1 ]
Mannes, Philip [1 ]
Warnick, Eugene [1 ]
Janowsky, Aaron [2 ,3 ,4 ]
Eshleman, Amy J. [2 ,3 ,4 ]
Gizewski, Elizabeth [5 ]
Brust, Tarsis F. [6 ,7 ]
Bohn, Laura M. [6 ,7 ]
Auchampach, John A. [5 ]
Gao, Zhan-Guo [1 ]
Jacobson, Kenneth A. [1 ]
机构
[1] NIDDK, Mol Recognit Sect, Lab Bioorgan Chem, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Res Serv R&D 22, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Psychiat, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[4] Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[5] Med Coll Wisconsin, Dept Pharmacol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[6] Scripps Res Inst, Dept Mol Med, 130 Scripps Way, Jupiter, FL 33458 USA
[7] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA
来源
ACS OMEGA | 2018年 / 3卷 / 10期
关键词
CHRONIC NEUROPATHIC PAIN; 18 KDA TSPO; INDUCED CONSTIPATION; PROTEIN; LIGANDS; BINDING; POTENT; EFFICACY; DESIGN; CANCER;
D O I
10.1021/acsomega.8b01237
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
While screening off-target effects of rigid (N)-methanocarba-adenosine 5'-methylamides as A(3) adenosine receptor (AR) agonists, we discovered mu M binding hits at the d-opioid receptor (DOR) and translocator protein (TSPO). In an effort to increase OR and decrease AR affinity by structure activity analysis of this series, antagonist activity at kappa-(K)OR appeared in 5'-esters (ethyl 24 and propyl 30), which retained TSPO interaction (mu M). 7-Deaza modification of C2-(arylethynyl)-5'-esters but not 4'-truncation enhanced KOR affinity (MRS7299 28 and 29, K-1 approximate to 40 nM), revealed mu-OR and DOR binding, and reduced AR affinity. Molecular docking and dynamics simulations located a putative KOR binding mode consistent with the observed affinities, placing C7 in a hydrophobic region. 3-Deaza modification permitted TSPO but not OR binding, and 1-deaza was permissive to both; ribose-restored analogues were inactive at both. Thus, we have repurposed a known AR nucleoside scaffold for OR antagonism, with a detailed hypothesis for KOR recognition.
引用
收藏
页码:12658 / 12678
页数:21
相关论文
共 55 条
[1]   Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation [J].
Anantharamu, Tejus ;
Sharma, Sushil ;
Gupta, Ajay Kumar ;
Dahiya, Navdeep ;
Brashier, Dick B. Singh ;
Sharma, Ashok Kumar .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (03) :188-192
[2]   Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides [J].
Barresi, Elisabetta ;
Bruno, Agostino ;
Taliani, Sabrina ;
Cosconati, Sandro ;
Da Pozzo, Eleonora ;
Salerno, Silvia ;
Simorini, Francesca ;
Daniele, Simona ;
Giacomelli, Chiara ;
Marini, Anna Maria ;
La Motta, Concettina ;
Marinelli, Luciana ;
Cosimelli, Barbara ;
Novellino, Ettore ;
Greco, Giovanni ;
Da Settimo, Federico ;
Martini, Claudia .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) :6081-6092
[3]   Automated design of ligands to polypharmacological profiles [J].
Besnard, Jeremy ;
Ruda, Gian Filippo ;
Setola, Vincent ;
Abecassis, Keren ;
Rodriguiz, Ramona M. ;
Huang, Xi-Ping ;
Norval, Suzanne ;
Sassano, Maria F. ;
Shin, Antony I. ;
Webster, Lauren A. ;
Simeons, Frederick R. C. ;
Stojanovski, Laste ;
Prat, Annik ;
Seidah, Nabil G. ;
Constam, Daniel B. ;
Bickerton, G. Richard ;
Read, Kevin D. ;
Wetsel, William C. ;
Gilbert, Ian H. ;
Roth, Bryan L. ;
Hopkins, Andrew L. .
NATURE, 2012, 492 (7428) :215-+
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Development of κ Opioid Receptor Antagonists [J].
Carroll, F. Ivy ;
Carlezon, William A., Jr. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) :2178-2195
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy [J].
Costa, Barbara ;
Da Pozzo, Eleonora ;
Giacomelli, Chiara ;
Barresi, Elisabetta ;
Taliani, Sabrina ;
Da Settimo, Federico ;
Martini, Claudia .
SCIENTIFIC REPORTS, 2016, 6
[8]   Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit [J].
Crowley, Nicole A. ;
Bloodgood, Daniel W. ;
Hardaway, J. Andrew ;
Kendra, Alexis M. ;
McCall, Jordan G. ;
Al-Hasani, Ream ;
McCall, Nora M. ;
Yu, Waylin ;
Schools, Zachary L. ;
Krashes, Michael J. ;
Lowell, Bradford B. ;
Whistler, Jennifer L. ;
Bruchas, Michael R. ;
Kash, Thomas L. .
CELL REPORTS, 2016, 14 (12) :2774-2783
[9]   TSPO PIGA Ligands Promote Neurosteroidogenesis and Human Astrocyte Well-Being [J].
Da Pozzo, Eleonora ;
Giacomelli, Chiara ;
Costa, Barbara ;
Cavallini, Chiara ;
Taliani, Sabrina ;
Barresi, Elisabetta ;
Da Settimo, Federico ;
Martini, Claudia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
[10]   Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs [J].
Dale, Elena ;
Bang-Andersen, Benny ;
Sanchez, Connie .
BIOCHEMICAL PHARMACOLOGY, 2015, 95 (02) :81-97